Related Experiment Video
Updated: Jul 18, 2025

08:09
Gene-environment Interaction Models to Unmask Susceptibility Mechanisms in Parkinson's Disease
Published on: January 7, 2014
7.6K
CENTRAL AND PERIPHERAL EFFECT OF MPTP VIA DOSE-DEPENDENT MAGNESIUM MODULATION
R Lefter1, I M Balmus2, A Ciobica1,3,4
1Centre of Biomedical Research, Romanian Academy, Iasi, Romania.
Summary
MPTP causes constipation and behavioral changes in rats, which are worsened by low magnesium. Magnesium intake may mitigate these MPTP-induced effects, highlighting its role beyond the central nervous system.
Area of Science:
- Neuroscience
- Gastroenterology
- Toxicology
Background:
- MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) may induce gastrointestinal motility deficits and central nervous system (CNS) effects.
- Magnesium's neuroprotective, gastrointestinal, and antioxidant roles suggest a potential interaction with MPTP-induced impairments.
Purpose of the Study:
- To investigate the modulatory effects of varied magnesium intake on MPTP neurotoxicity.
- To assess magnesium's impact on MPTP-induced functional gastrointestinal impairments.
Main Methods:
- Rats received magnesium-controlled diets and enriched drinking water before MPTP administration.
- Gastrointestinal motility, behavioral patterns (Y maze, elevated plus maze, open field, forced swim tests), and oxidative stress markers in brain and bowel were evaluated.
Main Results:
- MPTP induced magnesium intake-dependent constipation, anxiety- and depressive-like behaviors, and altered pain tolerance.
- Magnesium-dependent oxidative stress was observed in both brain and intestinal tissues.
Conclusions:
- MPTP's systemic effects extend beyond the CNS to the gastrointestinal system.
- Magnesium intake may play a crucial role in mitigating MPTP-induced abnormalities, suggesting its importance in managing neurotoxin-related conditions.
Keywords:
MPTPParkinson’s diseaseanimal modelanxious behaviordepressive-like behaviorgastrointestinallocomotor impairmentMore Related Videos
Related Concept Videos
Drugs Affecting Neurotransmitter Synthesis
1.4K
Drugs affecting neurotransmitter synthesis can impact the adrenergic neuron and the synthesis of neurotransmitters. For example, α-methyltyrosine and carbidopa target specific enzymes involved in catecholamine synthesis. α-methyltyrosine inhibits the enzyme tyrosine hydroxylase, which converts tyrosine into dopamine. By blocking this enzyme, α-methyltyrosine reduces dopamine production and other catecholamines. Carbidopa, on the other hand, inhibits the enzyme dopa decarboxylase,...
1.4K
Parkinson's Disease: Treatment
297
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
297

